SK284668B6 - Tenká adhezívna náplasť zahrnujúca betametazón a kyselinu hyalurónovú na liečbu psoriázy, dermatitídy a dermatózy - Google Patents

Tenká adhezívna náplasť zahrnujúca betametazón a kyselinu hyalurónovú na liečbu psoriázy, dermatitídy a dermatózy Download PDF

Info

Publication number
SK284668B6
SK284668B6 SK40-2000A SK402000A SK284668B6 SK 284668 B6 SK284668 B6 SK 284668B6 SK 402000 A SK402000 A SK 402000A SK 284668 B6 SK284668 B6 SK 284668B6
Authority
SK
Slovakia
Prior art keywords
adhesive
adhesive patch
patch according
weight
layer
Prior art date
Application number
SK40-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK402000A3 (en
Inventor
Elisabetta Donati
Irina Rapaport
Original Assignee
Altergon S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon S.A. filed Critical Altergon S.A.
Publication of SK402000A3 publication Critical patent/SK402000A3/sk
Publication of SK284668B6 publication Critical patent/SK284668B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK40-2000A 1999-03-05 2000-01-13 Tenká adhezívna náplasť zahrnujúca betametazón a kyselinu hyalurónovú na liečbu psoriázy, dermatitídy a dermatózy SK284668B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000449A IT1309588B1 (it) 1999-03-05 1999-03-05 Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi.

Publications (2)

Publication Number Publication Date
SK402000A3 SK402000A3 (en) 2000-09-12
SK284668B6 true SK284668B6 (sk) 2005-08-04

Family

ID=11382159

Family Applications (1)

Application Number Title Priority Date Filing Date
SK40-2000A SK284668B6 (sk) 1999-03-05 2000-01-13 Tenká adhezívna náplasť zahrnujúca betametazón a kyselinu hyalurónovú na liečbu psoriázy, dermatitídy a dermatózy

Country Status (12)

Country Link
US (1) US6379695B1 (de)
EP (1) EP1034780B1 (de)
AT (1) ATE269697T1 (de)
CA (1) CA2288482C (de)
CZ (1) CZ295714B6 (de)
DE (1) DE60011686T2 (de)
DK (1) DK1034780T3 (de)
ES (1) ES2222860T3 (de)
HU (1) HU225599B1 (de)
IT (1) IT1309588B1 (de)
PT (1) PT1034780E (de)
SK (1) SK284668B6 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE320781T1 (de) * 2001-11-23 2006-04-15 Coloplast As Wundverband
US7887842B2 (en) * 2003-02-07 2011-02-15 Teikoku Pharma Usa, Inc. Methods of administering a dermatological agent to a subject
EP1566156B1 (de) * 2003-08-11 2008-10-08 Mycoal Co., Ltd. Heizelement
ES2299082T3 (es) * 2004-09-01 2008-05-16 Labtec Gesellschaft Fur Technologische Forschung Und Entwicklung Mbh Parche para cavidades.
US20070099867A1 (en) * 2005-05-24 2007-05-03 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
RU2342148C2 (ru) * 2005-09-26 2008-12-27 Гликосайенс Лабораториз, Инк. Фармацевтическое средство, содержащее гиалуронан в качестве активного ингредиента
JP2009091248A (ja) * 2006-01-17 2009-04-30 Toshitsu Kagaku Kenkyusho:Kk 外傷性神経障害および/または運動機能障害の治療薬
WO2008068854A1 (ja) 2006-12-05 2008-06-12 Glycoscience Laboratories, Inc. 変形性関節症の治療剤
FR2918892B1 (fr) * 2007-07-16 2010-02-12 Fabre Pierre Dermo Cosmetique Composition dermatologique anti-inflammatoire comprenant des corticoides et des fragments de hyaluronate, et ses utilisations
US20090307669A1 (en) * 2008-06-06 2009-12-10 Garst Jr Gerald Blaine Memory management for closures
FR2939317B1 (fr) * 2008-12-08 2010-12-24 Oreal Systeme de delivrance trans(epi)dermique comprenant une dispersion vesiculaire, procede de traitement cosmetique et utilisation cosmetique
CN108273115B (zh) * 2018-04-16 2020-06-16 山东威高药业股份有限公司 羟乙基淀粉在制作创面敷料中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JPS62169723A (ja) * 1986-01-22 1987-07-25 Teisan Seiyaku Kk 徐放化製剤
EP0282156B1 (de) 1987-03-09 1991-04-17 Alza Corporation Zusammensetzung zur Vorbeugung einer Kontaktallergie durch gleichzeitiges Verabreichen eines Kortikosteroids mit einem sensiblisierenden Arzneistoff
JP2945993B2 (ja) * 1989-12-05 1999-09-06 武田薬品工業株式会社 外用剤
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
US5173302A (en) 1990-09-28 1992-12-22 Medtronic, Inc. Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
CA2140901A1 (en) * 1992-07-23 1994-02-05 Naruhito Higo Basal drug composition for percutaneous administration and pharmaceutical composition thereof
AU3618795A (en) * 1994-10-05 1996-05-02 Hisamitsu Pharmaceutical Co., Inc. Drug compounding ingredients comprising n-substituted-o-toluidine derivative and percutaneously absorbable preparation
EP0752457B1 (de) * 1995-07-04 2001-09-05 Kowa Company Ltd. Hydrophiles Klebemittel
JP4275768B2 (ja) 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体

Also Published As

Publication number Publication date
HUP0000045A2 (hu) 2001-01-29
PT1034780E (pt) 2004-10-29
SK402000A3 (en) 2000-09-12
EP1034780A2 (de) 2000-09-13
DK1034780T3 (da) 2004-10-25
ITMI990449A1 (it) 2000-09-05
HU225599B1 (en) 2007-05-02
HU0000045D0 (en) 2000-03-28
CA2288482C (en) 2008-12-30
EP1034780B1 (de) 2004-06-23
CA2288482A1 (en) 2000-09-05
CZ295714B6 (cs) 2005-10-12
ES2222860T3 (es) 2005-02-16
EP1034780A3 (de) 2001-12-05
ATE269697T1 (de) 2004-07-15
IT1309588B1 (it) 2002-01-24
DE60011686D1 (de) 2004-07-29
US6379695B1 (en) 2002-04-30
DE60011686T2 (de) 2005-06-30
CZ200098A3 (cs) 2000-10-11

Similar Documents

Publication Publication Date Title
DE4241874C2 (de) Medizinisches Pflaster für die perkutane Verabreichung des Wirkstoffs Ketoprofen
EP0582727B1 (de) Transdermale therapeutische Formulierung
US20220133641A1 (en) Topical film-forming spray
JP2735392B2 (ja) 乾癬の治療法
EP1490038B1 (de) Mischsystem zur löslichkeitsvermittlung von pharmazeutischen wirkstoffen in polymermatrizes
SK284668B6 (sk) Tenká adhezívna náplasť zahrnujúca betametazón a kyselinu hyalurónovú na liečbu psoriázy, dermatitídy a dermatózy
KR19990029556A (ko) 디클로페낙 디에틸암모늄염을 함유한 매트릭스형진통 소염 경피투여제
KR20070080823A (ko) 활성약물 함유 상처 치료용 하이드로겔 제제
DE60116202T2 (de) Perkutan absorbierende Zubereitung
JP5813652B2 (ja) 経皮吸収型製剤
ITMI990834A1 (it) Cerotto per uso topico eparina e diclofenac
WO2001049273A2 (de) Pharmazeutische zusammensetzung zur transdermalen verabreichung von hormonen mit einem permeationsverbessernden zusatzstoff
KR100552650B1 (ko) 피록시캄 함유 소염진통용 플라스터
PT907359E (pt) Reservatorios para farmacos de hidrogel de poliuretano para utilizacao em sistemas de administracao transdermica de farmacos
JPS6059209B2 (ja) 複合製剤
KR20050095628A (ko) 얇은 수성 습포제
PL192091B1 (pl) Lecznicza kompozycja samoprzylepna do transdermalnego podawania estrogenu w połączeniu z gestagenem i jej zastosowanie
DE19828274C2 (de) Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE10025971B4 (de) Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
JPH0561249B2 (de)
JPH06172159A (ja) 複合粉体抗菌剤
JPH0331217A (ja) 経皮吸収促進組成物及びこれを含有する外用剤
CZ200192A3 (cs) Kompozice s obsahem glyceroltrinitrátu, způsob její výroby a použití

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20200113